Trillium Therapeutics Inc.

Ownership Transactions Reported by 14 Insiders

Industry
Pharmaceutical Preparations
Location
2488 Dunwin Drive, Mississauga, Ontario, Canada

There are no Buy or Sell transactions made by insiders since 9/9/2023

Trillium Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paolo Pucci Director Nov 17, 2021
Scott Dunseth Myers Director Nov 17, 2021
Paul Edward Walker Director Nov 17, 2021
Luke M. Beshar Director Nov 17, 2021
James T. Parsons Chief Financial Officer Nov 17, 2021
Michael E. Kamarck Director Nov 17, 2021
Robert Uger Chief Scientific Officer Nov 17, 2021
Rosemary Harrison Title: Senior Vice President, Corporate Development and Strategy Nov 17, 2021
Jan Skvarka President and CEO, Director Nov 17, 2021
Helen Tayton Martin Director Nov 17, 2021
Penka Petrova Chief Development Officer Nov 17, 2021
Ingmar Bruns Chief Medical Officer Nov 17, 2021
Catherine J. Mackey Director Nov 17, 2021
Benjamin Looker General Counsel Nov 17, 2021

Recent Insider Transactions by Companies or Individuals for Trillium Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.